Up to 85% of women with interstitial cystitis/bladder pain syndrome (IC/BPS) have pelvic floor dysfunction and hypertonicity. Current evaluation methodologies lack objective measures of pelvic floor muscle (PFM) activity.
Up to 85% of women with interstitial cystitis/bladder pain syndrome (IC/BPS) have pelvic floor dysfunction and hypertonicity. Current evaluation methodologies lack objective measures of pelvic floor muscle (PFM) activity.